CA2455425A1 - Water soluble extract from plant of solanum genus and the preparation process thereof, and pharmaceutical composition containing the water soluble extract - Google Patents
Water soluble extract from plant of solanum genus and the preparation process thereof, and pharmaceutical composition containing the water soluble extract Download PDFInfo
- Publication number
- CA2455425A1 CA2455425A1 CA002455425A CA2455425A CA2455425A1 CA 2455425 A1 CA2455425 A1 CA 2455425A1 CA 002455425 A CA002455425 A CA 002455425A CA 2455425 A CA2455425 A CA 2455425A CA 2455425 A1 CA2455425 A1 CA 2455425A1
- Authority
- CA
- Canada
- Prior art keywords
- water soluble
- soluble extract
- plant
- cancer cells
- water
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 title abstract 9
- 241000196324 Embryophyta Species 0.000 title abstract 3
- 235000002634 Solanum Nutrition 0.000 title abstract 3
- 241000207763 Solanum Species 0.000 title abstract 3
- 239000008194 pharmaceutical composition Substances 0.000 title abstract 2
- 238000002360 preparation method Methods 0.000 title 1
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 abstract 2
- 206010006187 Breast cancer Diseases 0.000 abstract 1
- 208000026310 Breast neoplasm Diseases 0.000 abstract 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 abstract 1
- 206010058467 Lung neoplasm malignant Diseases 0.000 abstract 1
- 206010028980 Neoplasm Diseases 0.000 abstract 1
- MBWUSSKCCUMJHO-ZGXDEBHDSA-N Solamargine Chemical compound O([C@@H]1[C@@H](CO)O[C@H]([C@@H]([C@H]1O)O[C@H]1[C@@H]([C@H](O)[C@@H](O)[C@H](C)O1)O)O[C@@H]1CC2=CC[C@H]3[C@@H]4C[C@H]5[C@@H]([C@]4(CC[C@@H]3[C@@]2(C)CC1)C)[C@@H]([C@]1(NC[C@H](C)CC1)O5)C)[C@@H]1O[C@@H](C)[C@H](O)[C@@H](O)[C@H]1O MBWUSSKCCUMJHO-ZGXDEBHDSA-N 0.000 abstract 1
- MBWUSSKCCUMJHO-DVDUUUGDSA-N Solamargine Natural products O([C@@H]1[C@@H](O)[C@@H](O[C@H]2[C@H](O)[C@H](O)[C@@H](O)[C@H](C)O2)[C@H](CO)O[C@@H]1O[C@@H]1CC=2[C@@](C)([C@@H]3[C@H]([C@H]4[C@@](C)([C@H]5[C@@H](C)[C@@]6(O[C@H]5C4)NC[C@H](C)CC6)CC3)CC=2)CC1)[C@H]1[C@H](O)[C@H](O)[C@@H](O)[C@@H](C)O1 MBWUSSKCCUMJHO-DVDUUUGDSA-N 0.000 abstract 1
- KNLOWJPFLKGYGQ-UHFFFAOYSA-N Solasodine 3-O-??-L-rhamnopyranosyl (1‘Â∆2)-O-[??-D-glucopyranosyl (1‘Â∆4)]-??-D-glucopyranoside Natural products O1C2(NCC(C)CC2)C(C)C(C2(CCC3C4(C)CC5)C)C1CC2C3CC=C4CC5OC(C(C1O)OC2C(C(O)C(O)C(C)O2)O)OC(CO)C1OC1OC(CO)C(O)C(O)C1O KNLOWJPFLKGYGQ-UHFFFAOYSA-N 0.000 abstract 1
- QCTMYNGDIBTNSK-UHFFFAOYSA-N Solasonin Natural products O1C2(NCC(C)CC2)C(C)C(C2(CCC3C4(C)CC5)C)C1CC2C3CC=C4CC5OC(C1OC2C(C(O)C(O)C(C)O2)O)OC(CO)C(O)C1OC1OC(CO)C(O)C(O)C1O QCTMYNGDIBTNSK-UHFFFAOYSA-N 0.000 abstract 1
- QCTMYNGDIBTNSK-QCNFCIKQSA-N Solasonine Natural products O([C@@H]1[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@@H](O)[C@H](C)O2)[C@@H](O[C@@H]2CC=3[C@@](C)([C@@H]4[C@H]([C@H]5[C@@](C)([C@H]6[C@@H](C)[C@@]7(O[C@H]6C5)NC[C@H](C)CC7)CC4)CC=3)CC2)O[C@@H](CO)[C@@H]1O)[C@H]1[C@@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 QCTMYNGDIBTNSK-QCNFCIKQSA-N 0.000 abstract 1
- 239000002253 acid Substances 0.000 abstract 1
- RCTKRNCKOYYRIO-UHFFFAOYSA-N alpha-Solamarine Natural products O1C2(NCC(C)CC2)C(C)C(C2(CCC3C4(C)CC5)C)C1CC2C3CC=C4CC5OC(C1O)OC(CO)C(O)C1OC1OC(CO)C(O)C(O)C1OC1OC(C)C(O)C(O)C1O RCTKRNCKOYYRIO-UHFFFAOYSA-N 0.000 abstract 1
- 239000007864 aqueous solution Substances 0.000 abstract 1
- 201000011510 cancer Diseases 0.000 abstract 1
- 230000005907 cancer growth Effects 0.000 abstract 1
- 238000000605 extraction Methods 0.000 abstract 1
- 230000007062 hydrolysis Effects 0.000 abstract 1
- 238000006460 hydrolysis reaction Methods 0.000 abstract 1
- 230000002401 inhibitory effect Effects 0.000 abstract 1
- 201000007270 liver cancer Diseases 0.000 abstract 1
- 208000014018 liver neoplasm Diseases 0.000 abstract 1
- 201000005202 lung cancer Diseases 0.000 abstract 1
- 208000020816 lung neoplasm Diseases 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 230000007935 neutral effect Effects 0.000 abstract 1
- 238000001556 precipitation Methods 0.000 abstract 1
- 238000000926 separation method Methods 0.000 abstract 1
- 239000002904 solvent Substances 0.000 abstract 1
- 238000011282 treatment Methods 0.000 abstract 1
- 230000004614 tumor growth Effects 0.000 abstract 1
- QCTMYNGDIBTNSK-XEAAVONHSA-N α-Solamarine Chemical compound O([C@H]1[C@@H](O)[C@@H](CO)O[C@H]([C@@H]1O[C@H]1[C@@H]([C@H](O)[C@@H](O)[C@H](C)O1)O)O[C@@H]1CC2=CC[C@H]3[C@@H]4C[C@H]5[C@@H]([C@]4(CC[C@@H]3[C@@]2(C)CC1)C)[C@@H]([C@]1(NC[C@H](C)CC1)O5)C)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O QCTMYNGDIBTNSK-XEAAVONHSA-N 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C01—INORGANIC CHEMISTRY
- C01G—COMPOUNDS CONTAINING METALS NOT COVERED BY SUBCLASSES C01D OR C01F
- C01G23/00—Compounds of titanium
- C01G23/04—Oxides; Hydroxides
- C01G23/047—Titanium dioxide
- C01G23/053—Producing by wet processes, e.g. hydrolysing titanium salts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
- A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/539—Scutellaria (skullcap)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B82—NANOTECHNOLOGY
- B82B—NANOSTRUCTURES FORMED BY MANIPULATION OF INDIVIDUAL ATOMS, MOLECULES, OR LIMITED COLLECTIONS OF ATOMS OR MOLECULES AS DISCRETE UNITS; MANUFACTURE OR TREATMENT THEREOF
- B82B3/00—Manufacture or treatment of nanostructures by manipulation of individual atoms or molecules, or limited collections of atoms or molecules as discrete units
Abstract
A water soluble extract from a plant of Solanum genus consists essentially of at least 60%-90% of solamargine and solasonine. A process for preparing the water soluble extract from the plant of Solanum genus involves the steps of hydrolysis with an acid, precipitation with a base, and separation treatments using chloroform, alcohol and water as extraction solvents. The water soluble extract prepared from the process can be directly dissolved in pure or neutral pH water to form a yellowish clear and transparent aqueous solution having a water solubility ranging from 2~20 mg/ml or higher. The water soluble extract can be used as an active component in a pharmaceutical composition for inhibiting the growth of tumor/cancer cells, in particular liver cancer cells, lung cancer cells and breast cancer cells.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| TW092115249A TWI300352B (en) | 2003-06-05 | 2003-06-05 | Water soluble extract from plant of solanum genus and the preparation process thereof, and pharmaceutical composition containing the water soluble extract |
| TW92115249 | 2003-06-05 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CA2455425A1 true CA2455425A1 (en) | 2004-12-05 |
| CA2455425C CA2455425C (en) | 2009-09-08 |
Family
ID=33488664
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA002455425A Expired - Lifetime CA2455425C (en) | 2003-06-05 | 2004-01-20 | Water soluble extract from plant of solanum genus and the preparation process thereof, and pharmaceutical composition containing the water soluble extract |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US7078063B2 (en) |
| JP (2) | JP3940928B2 (en) |
| KR (1) | KR100545723B1 (en) |
| AU (1) | AU2003236377B2 (en) |
| BR (1) | BR0305446A (en) |
| CA (1) | CA2455425C (en) |
| MY (1) | MY132659A (en) |
| NZ (1) | NZ529466A (en) |
| SG (1) | SG114627A1 (en) |
| TW (1) | TWI300352B (en) |
| ZA (1) | ZA200308812B (en) |
Families Citing this family (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2461928A1 (en) * | 2001-09-28 | 2003-04-10 | Glycomed Sciences Limited | Solvent extraction process |
| TWI300352B (en) | 2003-06-05 | 2008-09-01 | G & E Herbal Biotechnology Co Ltd | Water soluble extract from plant of solanum genus and the preparation process thereof, and pharmaceutical composition containing the water soluble extract |
| US7693887B2 (en) * | 2005-02-01 | 2010-04-06 | Strands, Inc. | Dynamic identification of a new set of media items responsive to an input mediaset |
| EP1849099B1 (en) * | 2005-02-03 | 2014-05-07 | Apple Inc. | Recommender system for identifying a new set of media items responsive to an input set of media items and knowledge base metrics |
| EP1844386A4 (en) * | 2005-02-04 | 2009-11-25 | Strands Inc | System for browsing through a music catalog using correlation metrics of a knowledge base of mediasets |
| EP1926027A1 (en) * | 2005-04-22 | 2008-05-28 | Strands Labs S.A. | System and method for acquiring and aggregating data relating to the reproduction of multimedia files or elements |
| US7877387B2 (en) * | 2005-09-30 | 2011-01-25 | Strands, Inc. | Systems and methods for promotional media item selection and promotional program unit generation |
| US20090070267A9 (en) * | 2005-09-30 | 2009-03-12 | Musicstrands, Inc. | User programmed media delivery service |
| EP2437158A1 (en) * | 2005-12-19 | 2012-04-04 | Apple Inc. | User-to-user recommender |
| US20070244880A1 (en) * | 2006-02-03 | 2007-10-18 | Francisco Martin | Mediaset generation system |
| EP2024811A4 (en) | 2006-02-10 | 2010-11-10 | Strands Inc | Systems and methods for prioritizing mobile media player files |
| MY150068A (en) * | 2007-07-25 | 2013-11-29 | Univ Putra Malaysia | Flavour enhancers/food seasoning from seaweeds and a method for producing thereof |
| US8601003B2 (en) | 2008-09-08 | 2013-12-03 | Apple Inc. | System and method for playlist generation based on similarity data |
| CN102058613B (en) * | 2011-01-12 | 2015-12-16 | 江苏先声药物研究有限公司 | The purposes of anti-tumor active ingredient compositions in Herba Solani Nigri |
| TWI414304B (en) * | 2011-05-04 | 2013-11-11 | G & E Herbal Biotechnology Co Ltd | Treatment of wart with a water soluble extract from plant of solanum genus |
| TWI476012B (en) * | 2011-05-12 | 2015-03-11 | G & E Herbal Biotechnology Co Ltd | Treatment and/or prevention of inflammation and cutaneous photodamage and photoprotection of the skin with a water soluble extract from plant of solanum genus |
| US8551187B1 (en) | 2012-04-23 | 2013-10-08 | Umm Al-Qura University | Topical depilatory and method of removing hair |
| US20160150789A1 (en) * | 2014-12-02 | 2016-06-02 | Bioprocol, Bioprocesos De Colombia Sas | Process to obtain an extract from solanum genus plants |
| CA3109613A1 (en) | 2016-05-28 | 2017-12-07 | Rajiv Gandhi Centre For Biotechnology, An Autonomous Institute Under The Department Of Bio-Technology, Government Of India | Uttroside b and derivatives thereof as therapeutics for hepatocellular carcinoma |
| WO2020105743A1 (en) * | 2018-11-19 | 2020-05-28 | 양상석 | Nutritional supplement, drug for cold and body aches, and drug for cancer prevention (strawberry cold-and-worm drug) |
| CN112138066B (en) * | 2020-09-09 | 2022-02-25 | 中南大学湘雅医院 | Application of black nightshade or black nightshade extract in increasing antibiotic or antineoplastic drug sensitivity |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3960839A (en) | 1973-02-09 | 1976-06-01 | Escuela Politecnica Nacional | Process for recovering and isolating solasodine and glycosides thereof |
| NZ193564A (en) * | 1979-05-02 | 1985-01-31 | Aruba Pty Ltd | Steroid alkaloids from solanum sodomeum and pharmaceutical compositions |
| BR9105952A (en) | 1990-01-18 | 1992-11-17 | Cura Nominees Pty Ltd | METHOD FOR IDENTIFYING COMPOUND AND TO CONTROL CELLULAR AUTOPHAGY, MOBILE CELLULAR IMMOBILIZATION, CELLULAR IMMOBILIZATION, CANCER TREATMENT METHOD, CONTRACEPTION, PREGNANCY TERMINATION, REMOVAL OF ORGANIZATION, PATHOGENIC AND DEVELOPMENTAL COSTS IN AN ANIMAL BODY, METHOD OF MARKING AND IDENTIFYING TARGET CELL, COMPOUND AND COMPOSITION CONTAINING AT LEAST ONE COMPOUND TO CONTROL CELL AUTOPHAGY, AGGUUTINATION OR IMMOBILIZATION OF MOBILE CELLS |
| WO1998058650A1 (en) | 1997-06-20 | 1998-12-30 | University Of Utah Research Foundation | Use of plant-alkaloids to enhance innate immunity defense mechanisms |
| AUPP968699A0 (en) | 1999-04-09 | 1999-05-06 | Cura Nominees Pty Ltd | Therapeutic compositions and method for their preparation |
| US6180154B1 (en) | 1999-04-28 | 2001-01-30 | The State Of Oregon Acting By And Through The State Board Of Higher Education On Behalf Of Oregon State University | Natural colorant from potato extract |
| TW471968B (en) | 1999-08-25 | 2002-01-11 | Committee On Chinese Medicine | Solamargine pharmaceutical composition for killing cancer cells |
| CA2461928A1 (en) * | 2001-09-28 | 2003-04-10 | Glycomed Sciences Limited | Solvent extraction process |
| TWI300352B (en) | 2003-06-05 | 2008-09-01 | G & E Herbal Biotechnology Co Ltd | Water soluble extract from plant of solanum genus and the preparation process thereof, and pharmaceutical composition containing the water soluble extract |
-
2003
- 2003-06-05 TW TW092115249A patent/TWI300352B/en not_active IP Right Cessation
- 2003-08-13 MY MYPI20033088A patent/MY132659A/en unknown
- 2003-08-15 SG SG200304831A patent/SG114627A1/en unknown
- 2003-08-20 AU AU2003236377A patent/AU2003236377B2/en not_active Ceased
- 2003-08-29 US US10/650,942 patent/US7078063B2/en not_active Expired - Lifetime
- 2003-08-29 JP JP2003306481A patent/JP3940928B2/en not_active Expired - Fee Related
- 2003-08-29 KR KR1020030060161A patent/KR100545723B1/en not_active IP Right Cessation
- 2003-11-11 NZ NZ529466A patent/NZ529466A/en not_active IP Right Cessation
- 2003-11-12 ZA ZA200308812A patent/ZA200308812B/en unknown
- 2003-11-18 BR BR0305446-2A patent/BR0305446A/en not_active Application Discontinuation
-
2004
- 2004-01-20 CA CA002455425A patent/CA2455425C/en not_active Expired - Lifetime
-
2006
- 2006-12-18 JP JP2006339796A patent/JP2007145849A/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| JP3940928B2 (en) | 2007-07-04 |
| JP2007145849A (en) | 2007-06-14 |
| BR0305446A (en) | 2005-05-17 |
| SG114627A1 (en) | 2005-09-28 |
| TW200427455A (en) | 2004-12-16 |
| KR20040105530A (en) | 2004-12-16 |
| JP2004359661A (en) | 2004-12-24 |
| ZA200308812B (en) | 2006-05-31 |
| NZ529466A (en) | 2005-03-24 |
| US20040247715A1 (en) | 2004-12-09 |
| AU2003236377A1 (en) | 2004-12-23 |
| US7078063B2 (en) | 2006-07-18 |
| CA2455425C (en) | 2009-09-08 |
| KR100545723B1 (en) | 2007-04-12 |
| AU2003236377B2 (en) | 2006-08-17 |
| MY132659A (en) | 2007-10-31 |
| TWI300352B (en) | 2008-09-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA2455425A1 (en) | Water soluble extract from plant of solanum genus and the preparation process thereof, and pharmaceutical composition containing the water soluble extract | |
| US20180168198A1 (en) | Nutritional composition | |
| EP0893449B1 (en) | Antitumor substance extracted from hen-of-the-woods | |
| CN103125780B (en) | Compound Chinese herbal preparation for improving testudinate immunity | |
| CN103073651B (en) | Ganoderan extraction method and ganoderan use | |
| CA2412600A1 (en) | Potent immunostimulatory polysaccharides extracted from microalgae | |
| EP1092765A2 (en) | Germination-activated red Ganoderma lucidum spores and method for producing the same | |
| WO2007124153A3 (en) | Water-soluble pharmaceutical compositions of hops resins | |
| WO2006113495A3 (en) | Dicarboxylic acid ester derivatives of ginsenoside, pharmaceutical preparations containing the same, and preparation thereof | |
| Bi et al. | Biological and physicochemical properties of two polysaccharides from the mycelia of Grifola umbellate | |
| US4952399A (en) | Pharmaceutical composition which inhibits the growth of a tumor | |
| DK1508334T3 (en) | Water-soluble plant extract from solanum, its preparation and pharmaceutical composition containing the water-soluble extract | |
| Zhao et al. | In vitro antioxidant and antitumor activities of polysaccharides extracted from the mycelia of liquid-cultured Flammulina velutipes | |
| CN112225825A (en) | Phellinus igniarius anti-hepatoma cell proliferation effective component and preparation method thereof | |
| KR20110112580A (en) | Manufacturing method of solubility propolice | |
| CN104593443A (en) | Preparation method of agilawood chromone component | |
| CN108575758A (en) | A kind of culture media composition of Herba Saussureae Involueratae tissue cultures and its application | |
| WO2007137602A1 (en) | Method of producing a liquid oral or otherwise applicable composition for administration to human beings and animals, liquid oral or otherwise applicable composition and its use of the composition for the manufacture of a product for functional nutrition | |
| CN1062596C (en) | Sea cucumber health care wine and preparation method | |
| CN108660175B (en) | A kind of plant source polypeptide and the application in cosmetics | |
| TW201139663A (en) | A method for cultuvating Cordyceps militaris | |
| CN102603754B (en) | Preparation method and application of quinolone alkaloids of Zanthoxylum nitidum | |
| CN102040749B (en) | Ganoderma sinense mycelium polysaccharide refined substance as well as preparation method and use thereof | |
| KR101156775B1 (en) | Anti-cancer activity of Ganoderma lucidum extract, and extractive method using basic alcohol | |
| CN103145671B (en) | Application of aspergillus awamori in preparation of quercetin by fermenting lichee peel |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| EEER | Examination request | ||
| MKEX | Expiry |
Effective date: 20240122 |